BankUnited Seeks Shareholder Approval for Amended Equity Incentive Plan with 5.81% Potential Dilution
summarizeSummary
BankUnited filed its definitive proxy statement, seeking shareholder approval for an amended equity incentive plan that could result in 5.81% potential dilution, alongside routine proposals for director elections, auditor ratification, and executive compensation.
check_boxKey Events
-
Proposed Equity Incentive Plan Expansion
Shareholders will vote on approving an Amended and Restated 2023 Omnibus Equity Incentive Plan, increasing the share reserve by 1,500,000 shares and extending its term. This results in a total potential dilution (overhang) of 5.81% of fully-diluted common stock outstanding.
-
Strong Governance Features in Equity Plan
The proposed equity plan includes robust governance provisions such as no evergreen clause, double-trigger change-in-control vesting, prohibition on option repricing, a $500,000 limit on non-employee director compensation, and a clawback policy.
-
Routine Shareholder Meeting Proposals
The proxy statement includes standard proposals for the election of nine directors, the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2026, and an advisory 'say-on-pay' vote on executive compensation.
-
Continued Capital Allocation Strategy
The company reiterated its commitment to returning capital to shareholders through dividends and existing share repurchase programs, including a $200 million authorization in January 2026 and a $100 million program in July 2025, balancing capital deployment with incentive compensation needs.
auto_awesomeAnalysis
BankUnited, Inc. has filed its definitive proxy statement (DEF 14A) for its upcoming Annual Meeting on May 21, 2026. The most significant proposal is the approval of the Amended and Restated 2023 Omnibus Equity Incentive Plan, which seeks to increase the share reserve by 1,500,000 shares and extend the plan's termination date. This increase, combined with existing outstanding awards and shares available for grant, results in a total potential dilution (overhang) of 5.81% of fully-diluted common stock outstanding. While this represents a notable potential dilution, the plan incorporates strong governance features such as no evergreen provision, double-trigger change-in-control vesting, prohibition on repricing options, a $500,000 limit on non-employee director compensation, and a clawback policy. The company also highlights its strong 2025 financial performance, including a 15% increase in diluted EPS and a 16% rise in pre-provision net revenue, alongside a commitment to returning capital to shareholders through dividends and existing share repurchase programs (a $200 million program authorized in January 2026 and a $100 million program in July 2025). This indicates a balanced capital allocation strategy despite the proposed equity issuance for incentive purposes. Other proposals include the routine election of nine directors, ratification of Deloitte & Touche LLP as the independent auditor, and an advisory 'say-on-pay' vote for executive compensation, which received 81% approval in 2025.
At the time of this filing, BKU was trading at $46.66 on NYSE in the Finance sector, with a market capitalization of approximately $3.4B. The 52-week trading range was $28.49 to $52.11. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.